Cargando…
Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
Pediatric acute lymphoblastic leukemia (ALL) is the most common subtype of childhood leukemia, which is characterized by the abnormal proliferation and accumulation of immature lymphoid cell in the bone marrow. Although the long-term survival rate for pediatric ALL has made significant progress over...
Autores principales: | Lv, Meng, Liu, Yan, Liu, Wei, Xing, Yabing, Zhang, Shengnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234114/ https://www.ncbi.nlm.nih.gov/pubmed/35769486 http://dx.doi.org/10.3389/fimmu.2022.921894 |
Ejemplares similares
-
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022) -
Recent advances in the management of pediatric acute lymphoblastic leukemia
por: Starý, Jan, et al.
Publicado: (2016) -
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives
por: Caracciolo, Daniele, et al.
Publicado: (2023) -
Recent advances on blinatumomab for acute lymphoblastic leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019) -
A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia
por: Drożak, Paulina, et al.
Publicado: (2022)